mvp
MVP: Pharmaceutical Turnaround - From Pain to Gain
Updated 8 Oct 2025
Pharmaceutical turnaround story trading at $0.615 vs $0.94 fair value. 54% upside potential with 31% European growth and operational recovery to 8.1% EBITDA margins.
View note